Library — CHDR

Search

Filter

Cannabis coadministration potentiates the effects of "ecstasy" on heart rate and temperature in humans.

Dumont GJ, Kramers C, Sweep FC, Touw DJ, van Hasselt JG, de Kam M, van Gerven JM, Buitelaar JK, Verkes RJ

Clinical pharmacology and therapeutics, 2009 Jul; 86(2):160-6

View publication
Validating a human model for anxiety using startle potentiated by cue and context: the effects of alprazolam, pregabalin, and diphenhydramine.

Baas JM, Mol N, Kenemans JL, Prinssen EP, Niklson I, Xia-Chen C, Broeyer F, van Gerven J

Psychopharmacology, 2009 Jun; 205(1):73-84

View publication
Pharmacology of rising oral doses of 5-hydroxytryptophan with carbidopa.

Smarius LJ, Jacobs GE, Hoeberechts-Lefrandt DH, de Kam ML, van der Post JP, de Rijk R, van Pelt J, Schoemaker RC, Zitman FG, van Gerven JM, Gijsman HJ

Journal of psychopharmacology (Oxford, England), 2008 May; 22(4):426-33

View publication
Evaluation of a vaporizing device (Volcano) for the pulmonary administration of tetrahydrocannabinol.

Hazekamp A, Ruhaak R, Zuurman L, van Gerven J, Verpoorte R

Journal of pharmaceutical sciences, 2006 Jun; 95(6):1308-17

View publication
Pharmacokinetic/pharmacodynamic assessment of tolerance to central nervous system effects of a 3 mg sustained release tablet of rilmenidine in hypertensive patients.

van der Post JP, de Visser SJ, Schoemaker RC, Cohen AF, van Gerven JM

Journal of psychopharmacology (Oxford, England), 2004 May; 18(2):221-7

View publication
The application of the principles of clinical drug development to pharmacological challenge tests of the serotonergic system.

Gijsman HJ, Cohen AF, van Gerven JM

Journal of psychopharmacology (Oxford, England), 2004 Feb; 18(1):7-13

View publication
No evidence of the usefulness of eye blinking as a marker for central dopaminergic activity.

van der Post J, de Waal PP, de Kam ML, Cohen AF, van Gerven JM

Journal of psychopharmacology (Oxford, England), 2004 Feb; 18(1):109-14

View publication
Evaluation of tests of central nervous system performance after hypoxemia for a model for cognitive impairment.

van der Post J, Noordzij LA, de Kam ML, Blauw GJ, Cohen AF, van Gerven JM

Journal of psychopharmacology (Oxford, England), 2002 Nov; 16(4):337-43

View publication
Placebo-controlled comparison of three dose-regimens of 5-hydroxytryptophan challenge test in healthy volunteers.

Gijsman HJ, van Gerven JM, de Kam ML, Schoemaker RC, Pieters MS, Weemaes M, de Rijk R, van der Post J, Cohen AF

Journal of clinical psychopharmacology, 2002 Apr; 22(2):183-9

View publication

«
1
2
3
4
5
6
»